In the BioHarmony Drug Report Database

"Preview" Icon

Polyethylene glycol

Miralax, Mircera (polyethylene glycol) is a small molecule pharmaceutical. Polyethylene glycol was first approved as Miralax on 2006-10-06. It has been approved in Europe to treat anemia and chronic kidney failure.

 

Trade Name

 

Mircera
 

Common Name

 

polyethylene glycol
 

ChEMBL ID

 

CHEMBL1201478
 

Indication

 

anemia, chronic kidney failure
 

Drug Class

 

Image (chem structure or protein)

Polyethylene glycol structure rendering